Rule et al. [29] showed that the biases of the cystatin C-based estimating equation differed for specific patient groups such as those with native kidney disease, kidney transplant recipients, and potential kidney donors, suggesting that non-GFR determinants impact serum cystatin C levels considerably. This evidence concerns the gene CST3 and kidney disorder.